clinical trial · NCT00915837
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
SurModics, Inc.·phase1·completed·n = 31
Diabetic Macular Edematriamcinolone acetonidetriamcinolone acetonide
brief summary
This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical intravitreal triamcinolone implant for the treatment of diabetic macular edema over a three-year period.
started
Jun 1, 2005
primary completion
Apr 1, 2009
completion
May 1, 2009
last updated
Jun 9, 2023
detailed description
The Helical Intravitreal Triamcinolone Implant is intended to provide sustained release of triamcinolone acetonide into the vitreous chamber of the eye.
official title
Phase 1 Prospective, Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Tolerability of Two Dose Levels of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol